Novartis pays big fine for bribing doctors in the US
Swiss pharma company Novartis will pay $729 million (CHF688 million) to US authorities in an out-of-court settlement over various charges, including that the company bribed doctors to use its drugs.
This content was published on
2 minutes
Keystone-SDA/dos
Audrey Strauss, the acting Manhattan US Attorney, said the firm had paid out for “speaking fees, exorbitant meals, and top-shelf alcohol that were nothing more than bribes to get doctors across the country to prescribe Novartis’s drugs.”
Essentially, Novartis admitted to having organised thousands of lavish conferences and events ostensibly aimed at “further education”. Guest speakers were paid large amounts to attend.
In return, the doctors were incentivised to prescribe Novartis products, such as drugs for high blood pressure and diabetes, which were then reimbursed by state health authorities.
“Not only did Novartis incentivise doctors to host these speaking events, reps bribed the doctors to write more prescriptions of the company’s drugs to give Novartis an advantage over competitors within their field,” said William F Sweeney Jr, head of New York’s FBI office.
“Greed replaced the responsibility the public expects from those who practice medicine.”
As part of the agreement with US authorities, Novartis has signed a five-year code of good conduct. The Basel-based firm also said on Thursday that it was revising its methods of providing medical training, notably by planning more online webinars.
In a statement, Novartis CEO Vas Narasimhan said that the company had already changed (the charges in question were raised by a whistle-blower in 2011) and that it had “new leadership, a stronger culture, and a more comprehensive commitment to ethics”.
“With these agreements we mark an important milestone on our journey to build trust with society as we continue re-imagining medicine to improve and extend lives all around the world,” Narasimhan said.
A week ago Novartis and two of its subsidiaries admitted to further bribery schemes involving dealings in Vietnam and Greece, and agreed to pay some $347 million to settle US investigations.
As of Thursday, the stock market has not reacted particularly strongly: the Novartis share price dropped 0.8%, around the same as its competitor Roche.
Popular Stories
More
Workplace Switzerland
Meet the foreigners who make up a quarter of the Swiss population
What can be done to protect biodiversity in your country?
Swiss voters are set to decide on a people’s initiative calling for better protection of ecosystems in the country. Have your say on the September 22 vote.
Switzerland to host Ukraine mine action conference in October
This content was published on
Together with Ukraine, Switzerland is organising the Ukraine Mine Action Conference (UMAC2024) in Lausanne on October 17 and 18.
Switzerland revises pension expenditure downwards by billions
This content was published on
The Swiss government has corrected downwards the projected expenditure on old-age and survivor insurance in 2033 by CHF2.5 billion ($2.66 billion).
Excess mortality rate post-Covid could persist until 2033
This content was published on
According to a report by reinsurer Swiss Re, many countries are still experiencing excess mortality following the Covid-19 pandemic.
Swiss Army ends clean-up operation in storm-hit Maggia Valley
This content was published on
The Swiss Armed Forces completed 76 flight hours during the clean-up operation following the storm in the Maggia Valley in Ticino at the end of June.
Swiss cruise ship stranded on Danube River after heavy rains
This content was published on
Passengers on a Swiss river-cruise ship stranded on the Danube following heavy rainfall are still unable to disembark in Vienna due to flooding.
Golden eagles get better at flying over time, say Swiss researchers
This content was published on
Golden eagles perfect their flight as they age and learn to make better use of air currents, says a new study co-produced by Swiss researchers.
This content was published on
Public libraries in Switzerland recorded 46.3 million admissions last year, 7.4 million more than in 2022, says the Federal Statistical Office.
Swiss conservative party seeks referendum against Eurovision contest
This content was published on
The Swiss Federal Democratic Union is launching a referendum to prevent the Eurovision Song Contest from taking place in Basel next year.
Switzerland nabs 15 medals at WorldSkills championship
This content was published on
Swiss professionals have won 15 medals at the WorldSkills Championships in Lyon, France for the best finish by a European nation.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Novartis CEO warns that data on Covid-19 drugs is missing
This content was published on
Potential pharmaceutical solutions to combat Covid-19 must have strong clinical data to back their efficacy, according to Novartis boss Vasant Narasimhan.
US Senate asks Novartis to shed light on data manipulation allegations
This content was published on
The Swiss pharmaceutical firm Novartis has been asked to provide details regarding possible data inaccuracies for its human gene therapy Zolgensma.
Swiss pharma giants swallow up start-ups in push for next big gene therapy
This content was published on
Swiss drug makers are increasingly relying on buying science rather than doing it themselves in the search for the next big medical breakthrough.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.